Healing Drugs/Medicine-Infusion/Intravenous 0.9% Sodium Chloride Injection

• Application: Surgery
• Usage Mode: Intravenous Injection
• Suitable for: Elderly, Children, Adult
• State: Liquid
• Pharmaceutical Technology: Chemical Synthesis
• Transport Package: Carton
• Model NO.: 50ml-500ml
• Specification: 100ml: 0.9g
• Trademark: Huaren
• Origin: China

Product Description

Product Description

Drug name :Sodium chloride injection
Chemical name: Sodium chloride
Chemical structural formula: NaCl
Molecular formula: NaCl
Molecular weight: 58.44
Character:This product is colorless clear liquid.
Indications:
Dehydration caused by various reasons, including hypotonic, isotonic and hypertonic dehydration; hypertonic nonketotic diabetic coma, the application of isotonic or hypotonic sodium chloride can correct dehydration and hypertonic state; low chlorine metabolic alkalosis; rinse eyes and wash wounds with normal saline; it is also used for inducing abortion by water bag in obstetrics.
Specifications:

50ml:0.45g	Non PVC soft bags/PP
100ml:0.9g	Non PVC soft bags (single/double valve)
150ml:1.35g	GB
200ml:1.8g	GB
250ml:2.25g	Non PVC soft bags (single/double valve)
300ml:2.7g	Plastic bottle
500ml:4.5g	Non PVC soft bags (single valve; double valve)

Detailed Photos

 

Company Profile

  Founded in May 1998, Huaren Pharmaceutical is a modern pharmaceutical and health industry group integrating R&D, production and sales, focusing on medicine, health, medical equipment and medical services.
  In August 2010, the company was successfully listed on the Shenzhen Stock Exchange, the stock abbreviation is "Huaren Pharmaceutical", stock code "300110". In July 2019, the company underwent a change of shareholding, and the management committee of Xi'an Qujiang New Area became the actual controller of the company.
  After more than 20 years of development, the company's business focuses on nephrology, respiratory, fine hemp and large-volume preparations and other fields, and has successively built five production bases in Qingdao, Rizhao, Xiaogan, Pubei and Hefei, with a total production capacity of 950 million bags (bottles), and all production lines have passed the new GMP certification. The company's main products include small-volume injections, peritoneal dialysate, therapeutic infusions, basic infusions, medical devices, tablets, capsules, powders, granules, supporting drug packaging, health products and APIs, etc., with a total of 98 varieties and 212 specifications of existing drugs, realizing the integrated development of "raw materials + preparations + pharmaceutical packaging materials".

 

 

Certifications

 

Our Advantages

Pharmaceutical packaging materials,Rubber stoppers and APIs are self-produced and self-sold, the price is lower and the quality is more guaranteed.